Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 745 to 756 of 756 entries
Sorted by: Best Match Show Resources per page
Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications.

Internal medicine (Tokyo, Japan)

Hiramatsu D, Ogihara Y, Matsumoto T, Sato K, Takasaki A, Kurita T, Okamoto R, Wada H, Dohi K.
PMID: 34334565
Intern Med. 2021 Jul 30; doi: 10.2169/internalmedicine.7542-21. Epub 2021 Jul 30.

Congenital afibrinogenemia is a rare autosomal recessive blood disorder that accompanies thrombotic complications and is associated with bleeding tendency. The management of these opposing complications remains a challenge. Endovascular treatment (EVT) for peripheral arterial thrombosis has not been described...

Cite
Hiramatsu D, Ogihara Y, Matsumoto T, et al. Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications. Intern Med. 2021;doi: 10.2169/internalmedicine.7542-21.
Hiramatsu, D., Ogihara, Y., Matsumoto, T., Sato, K., Takasaki, A., Kurita, T., Okamoto, R., Wada, H., & Dohi, K. (2021). Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications. Internal medicine (Tokyo, Japan), . https://doi.org/10.2169/internalmedicine.7542-21
Hiramatsu, Daisuke, et al. "Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications." Internal medicine (Tokyo, Japan) vol. (2021). doi: https://doi.org/10.2169/internalmedicine.7542-21
Hiramatsu D, Ogihara Y, Matsumoto T, Sato K, Takasaki A, Kurita T, Okamoto R, Wada H, Dohi K. Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications. Intern Med. 2021 Jul 30; doi: 10.2169/internalmedicine.7542-21. Epub 2021 Jul 30. PMID: 34334565.
Copy Download .nbib Format: NLM
Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium.

Pulmonary circulation

Omori T, Nakamori S, Ohta-Ogo K, Matsuda A, Ogihara Y, Yamada N, Imanaka-Yoshida K, Ito M, Dohi K.
PMID: 33282187
Pulm Circ. 2020 Nov 23;10(4):2045894020960600. doi: 10.1177/2045894020960600. eCollection 2020.

Pulmonary capillary hemangiomatosis is a rare form of pulmonary artery hypertension; to date, only few descriptions of myocardial pathology in pulmonary capillary hemangiomatosis have been reported in the literature. We report the case of a Japanese female patient who...

Cite
Omori T, Nakamori S, Ohta-Ogo K, et al. Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium. Pulm Circ. 2020;10(4):2045894020960600doi: 10.1177/2045894020960600.
Omori, T., Nakamori, S., Ohta-Ogo, K., Matsuda, A., Ogihara, Y., Yamada, N., Imanaka-Yoshida, K., Ito, M., & Dohi, K. (2020). Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium. Pulmonary circulation, 10(4), 2045894020960600. https://doi.org/10.1177/2045894020960600
Omori, Taku, et al. "Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium." Pulmonary circulation vol. 10,4 (2020): 2045894020960600. doi: https://doi.org/10.1177/2045894020960600
Omori T, Nakamori S, Ohta-Ogo K, Matsuda A, Ogihara Y, Yamada N, Imanaka-Yoshida K, Ito M, Dohi K. Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium. Pulm Circ. 2020 Nov 23;10(4):2045894020960600. doi: 10.1177/2045894020960600. eCollection 2020. PMID: 33282187; PMCID: PMC7686619.
Copy Download .nbib Format: NLM
Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial.

Cardiovascular diabetology

Kusunose K, Imai T, Tanaka A, Dohi K, Shiina K, Yamada T, Kida K, Eguchi K, Teragawa H, Takeishi Y, Ohte N, Yamada H, Sata M, Node K.
PMID: 34521417
Cardiovasc Diabetol. 2021 Sep 14;20(1):186. doi: 10.1186/s12933-021-01380-w.

BACKGROUND: Identification of the effective subtypes of treatment for heart failure (HF) is an essential topic for optimizing treatment of the disorder. We hypothesized that the beneficial effect of SGLT2 inhibitors (SGLT2i) on the levels of N-terminal pro-brain natriuretic...

Cite
Kusunose K, Imai T, Tanaka A, et al. Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial. Cardiovasc Diabetol. 2021;20(1):186doi: 10.1186/s12933-021-01380-w.
Kusunose, K., Imai, T., Tanaka, A., Dohi, K., Shiina, K., Yamada, T., Kida, K., Eguchi, K., Teragawa, H., Takeishi, Y., Ohte, N., Yamada, H., Sata, M., Node, K. (2021). Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial. Cardiovascular diabetology, 20(1), 186. https://doi.org/10.1186/s12933-021-01380-w
Kusunose, Kenya, et al. "Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial." Cardiovascular diabetology vol. 20,1 (2021): 186. doi: https://doi.org/10.1186/s12933-021-01380-w
Kusunose K, Imai T, Tanaka A, Dohi K, Shiina K, Yamada T, Kida K, Eguchi K, Teragawa H, Takeishi Y, Ohte N, Yamada H, Sata M, Node K. Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial. Cardiovasc Diabetol. 2021 Sep 14;20(1):186. doi: 10.1186/s12933-021-01380-w. PMID: 34521417; PMCID: PMC8442416.
Copy Download .nbib Format: NLM
Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles.

Frontiers in chemistry

Takenaga N, Kumar R, Dohi T.
PMID: 33330391
Front Chem. 2020 Nov 20;8:599026. doi: 10.3389/fchem.2020.599026. eCollection 2020.

In recent years, the chemistry of heteroaryliodonium(III) salts has undergone significant developments. Heteroaryliodonium(III) salts have been found to be useful synthetic tools for the transfer of heteroaryl groups under metal-catalyzed and metal-free conditions for the preparation of functionalized heteroarene-containing...

Cite
Takenaga N, Kumar R, Dohi T. Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles. Front Chem. 2020;8:599026doi: 10.3389/fchem.2020.599026.
Takenaga, N., Kumar, R., & Dohi, T. (2020). Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles. Frontiers in chemistry, 8599026. https://doi.org/10.3389/fchem.2020.599026
Takenaga, Naoko, et al. "Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles." Frontiers in chemistry vol. 8 (2020): 599026. doi: https://doi.org/10.3389/fchem.2020.599026
Takenaga N, Kumar R, Dohi T. Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles. Front Chem. 2020 Nov 20;8:599026. doi: 10.3389/fchem.2020.599026. eCollection 2020. PMID: 33330391; PMCID: PMC7714995.
Copy Download .nbib Format: NLM
Psychological distress among Australian workers accessing the COVID-19 Superannuation Early Access Scheme.

The Australian and New Zealand journal of psychiatry

Choi I, Maxwell JK, Glozier N.
PMID: 34605313
Aust N Z J Psychiatry. 2021 Oct 04;48674211051280. doi: 10.1177/00048674211051280. Epub 2021 Oct 04.

No abstract available.

Cite
Choi I, Maxwell JK, Glozier N. Psychological distress among Australian workers accessing the COVID-19 Superannuation Early Access Scheme. Aust N Z J Psychiatry. 2021;48674211051280doi: 10.1177/00048674211051280.
Choi, I., Maxwell, J. K., & Glozier, N. (2021). Psychological distress among Australian workers accessing the COVID-19 Superannuation Early Access Scheme. The Australian and New Zealand journal of psychiatry, 48674211051280. https://doi.org/10.1177/00048674211051280
Choi, Isabella, et al. "Psychological distress among Australian workers accessing the COVID-19 Superannuation Early Access Scheme." The Australian and New Zealand journal of psychiatry vol. (2021): 48674211051280. doi: https://doi.org/10.1177/00048674211051280
Choi I, Maxwell JK, Glozier N. Psychological distress among Australian workers accessing the COVID-19 Superannuation Early Access Scheme. Aust N Z J Psychiatry. 2021 Oct 04;48674211051280. doi: 10.1177/00048674211051280. Epub 2021 Oct 04. PMID: 34605313.
Copy Download .nbib Format: NLM
μ-Oxo-Hypervalent-Iodine-Catalyzed Oxidative C-H Amination for Synthesis of Benzolactam Derivatives.

Chemical & pharmaceutical bulletin

Sasa H, Mori K, Kikushima K, Kita Y, Dohi T.
PMID: 34897163
Chem Pharm Bull (Tokyo). 2021 Dec 11; doi: 10.1248/cpb.c21-00980. Epub 2021 Dec 11.

Benzolactams have unique biological activity and high utility in the synthesis of valuable compounds with direct applicability to oxindole alkaloids and antibacterial agents. Despite recent advances in organic chemistry and the growing number of reported methods for synthesizing benzolactams,...

Cite
Sasa H, Mori K, Kikushima K, et al. μ-Oxo-Hypervalent-Iodine-Catalyzed Oxidative C-H Amination for Synthesis of Benzolactam Derivatives. Chem Pharm Bull (Tokyo). 2021;doi: 10.1248/cpb.c21-00980.
Sasa, H., Mori, K., Kikushima, K., Kita, Y., & Dohi, T. (2021). μ-Oxo-Hypervalent-Iodine-Catalyzed Oxidative C-H Amination for Synthesis of Benzolactam Derivatives. Chemical & pharmaceutical bulletin, . https://doi.org/10.1248/cpb.c21-00980
Sasa, Hirotaka, et al. "μ-Oxo-Hypervalent-Iodine-Catalyzed Oxidative C-H Amination for Synthesis of Benzolactam Derivatives." Chemical & pharmaceutical bulletin vol. (2021). doi: https://doi.org/10.1248/cpb.c21-00980
Sasa H, Mori K, Kikushima K, Kita Y, Dohi T. μ-Oxo-Hypervalent-Iodine-Catalyzed Oxidative C-H Amination for Synthesis of Benzolactam Derivatives. Chem Pharm Bull (Tokyo). 2021 Dec 11; doi: 10.1248/cpb.c21-00980. Epub 2021 Dec 11. PMID: 34897163.
Copy Download .nbib Format: NLM
Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1).

Heart and vessels

Takasaki A, Kurita T, Hirabayashi Y, Matsuo H, Tanoue A, Masuda J, Yamanaka T, Katayama K, Machida H, Ichikawa T, Ito M, Dohi K.
PMID: 34347137
Heart Vessels. 2021 Aug 04; doi: 10.1007/s00380-021-01919-7. Epub 2021 Aug 04.

Cardiovascular events and death are more prevalent in hemodialysis (HD) patients than in the general population. However, a detailed prognostic risk stratification of HD patients with acute myocardial infarction (AMI) has not yet been performed in the modern interventional...

Cite
Takasaki A, Kurita T, Hirabayashi Y, et al. Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1). Heart Vessels. 2021;doi: 10.1007/s00380-021-01919-7.
Takasaki, A., Kurita, T., Hirabayashi, Y., Matsuo, H., Tanoue, A., Masuda, J., Yamanaka, T., Katayama, K., Machida, H., Ichikawa, T., Ito, M., & Dohi, K. (2021). Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1). Heart and vessels, . https://doi.org/10.1007/s00380-021-01919-7
Takasaki, Akihiro, et al. "Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1)." Heart and vessels vol. (2021). doi: https://doi.org/10.1007/s00380-021-01919-7
Takasaki A, Kurita T, Hirabayashi Y, Matsuo H, Tanoue A, Masuda J, Yamanaka T, Katayama K, Machida H, Ichikawa T, Ito M, Dohi K. Prognosis of acute myocardial infarction in patients on hemodialysis stratified by Killip classification in the modern interventional era (focus on the prognosis of Killip class 1). Heart Vessels. 2021 Aug 04; doi: 10.1007/s00380-021-01919-7. Epub 2021 Aug 04. PMID: 34347137.
Copy Download .nbib Format: NLM
SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity.

Cellular immunology

Kim H, Byun JE, Yoon SR, Koohy H, Jung H, Choi I.
PMID: 34773897
Cell Immunol. 2022 Jan;371:104454. doi: 10.1016/j.cellimm.2021.104454. Epub 2021 Nov 07.

Immune dysregulation is commonly observed in patients with coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces severe lung inflammation and innate immune cell dysregulation. However, the precise interaction between SARS-CoV-2 and the innate immune system...

Cite
Kim H, Byun JE, Yoon SR, et al. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity. Cell Immunol. 2021;371:104454doi: 10.1016/j.cellimm.2021.104454.
Kim, H., Byun, J. E., Yoon, S. R., Koohy, H., Jung, H., & Choi, I. (2022). SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity. Cellular immunology, 371104454. https://doi.org/10.1016/j.cellimm.2021.104454
Kim, Hanna, et al. "SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity." Cellular immunology vol. 371 (2022): 104454. doi: https://doi.org/10.1016/j.cellimm.2021.104454
Kim H, Byun JE, Yoon SR, Koohy H, Jung H, Choi I. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity. Cell Immunol. 2022 Jan;371:104454. doi: 10.1016/j.cellimm.2021.104454. Epub 2021 Nov 07. PMID: 34773897; PMCID: PMC8577527.
Copy Download .nbib Format: NLM
Isolation, screening and identification of key components having intense insect repellent activity against Plodia interpunctella from four different medicinal plant materials.

Journal of the science of food and agriculture

Lee JS, Lee J, Choi I, Chang Y, Yoon CS, Han J.
PMID: 34322881
J Sci Food Agric. 2021 Jul 29; doi: 10.1002/jsfa.11447. Epub 2021 Jul 29.

BACKGROUND: Global warming and the indiscriminate use of pesticides have increased the propagation of the stored-product insect pests, leading to enormous losses in the agriculture and food industries. The most used insect repellents are synthetic derivatives; however, these have...

Cite
Lee JS, Lee J, Choi I, et al. Isolation, screening and identification of key components having intense insect repellent activity against Plodia interpunctella from four different medicinal plant materials. J Sci Food Agric. 2021;doi: 10.1002/jsfa.11447.
Lee, J. S., Lee, J., Choi, I., Chang, Y., Yoon, C. S., & Han, J. (2021). Isolation, screening and identification of key components having intense insect repellent activity against Plodia interpunctella from four different medicinal plant materials. Journal of the science of food and agriculture, . https://doi.org/10.1002/jsfa.11447
Lee, Jung-Soo, et al. "Isolation, screening and identification of key components having intense insect repellent activity against Plodia interpunctella from four different medicinal plant materials." Journal of the science of food and agriculture vol. (2021). doi: https://doi.org/10.1002/jsfa.11447
Lee JS, Lee J, Choi I, Chang Y, Yoon CS, Han J. Isolation, screening and identification of key components having intense insect repellent activity against Plodia interpunctella from four different medicinal plant materials. J Sci Food Agric. 2021 Jul 29; doi: 10.1002/jsfa.11447. Epub 2021 Jul 29. PMID: 34322881.
Copy Download .nbib Format: NLM
Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic.

Sports medicine - open

Shurlock J, Muniz-Pardos B, Tucker R, Bachl N, Papadopoulou T, Holloway G, Jones N, Bigard X, Vonbank K, Niederseer D, Meyer J, Nowak D, Debruyne A, Zupet P, Löllgen H, Steinacker JM, Wolfarth B, Bilzon JLJ, Ionescu A, Dohi M, Swart J, Constantinou D, Badtieva V, Zelenkova I, Casasco M, Geistlinger M, Fossati C, Fagnani F, Di Luigi L, Webborn N, Angeloudis K, Guppy FM, Singleton P, Miller M, Pigozzi F, Pitsiladis YP.
PMID: 33721127
Sports Med Open. 2021 Mar 15;7(1):19. doi: 10.1186/s40798-021-00309-7.

In an effort to reduce transmission and number of infections of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) virus, governments and official bodies around the world have produced guidelines on the use of face masks and...

Cite
Shurlock J, Muniz-Pardos B, Tucker R, et al. Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic. Sports Med Open. 2021;7(1):19doi: 10.1186/s40798-021-00309-7.
Shurlock, J., Muniz-Pardos, B., Tucker, R., Bachl, N., Papadopoulou, T., Holloway, G., Jones, N., Bigard, X., Vonbank, K., Niederseer, D., Meyer, J., Nowak, D., Debruyne, A., Zupet, P., Löllgen, H., Steinacker, J. M., Wolfarth, B., Bilzon, J. L. J., Ionescu, A., Dohi, M., Swart, J., Constantinou, D., Badtieva, V., Zelenkova, I., Casasco, M., Geistlinger, M., Fossati, C., Fagnani, F., Di Luigi, L., Webborn, N., Angeloudis, K., Guppy, F. M., Singleton, P., Miller, M., Pigozzi, F., & Pitsiladis, Y. P. (2021). Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic. Sports medicine - open, 7(1), 19. https://doi.org/10.1186/s40798-021-00309-7
Shurlock, Jonathan, et al. "Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic." Sports medicine - open vol. 7,1 (2021): 19. doi: https://doi.org/10.1186/s40798-021-00309-7
Shurlock J, Muniz-Pardos B, Tucker R, Bachl N, Papadopoulou T, Holloway G, Jones N, Bigard X, Vonbank K, Niederseer D, Meyer J, Nowak D, Debruyne A, Zupet P, Löllgen H, Steinacker JM, Wolfarth B, Bilzon JLJ, Ionescu A, Dohi M, Swart J, Constantinou D, Badtieva V, Zelenkova I, Casasco M, Geistlinger M, Fossati C, Fagnani F, Di Luigi L, Webborn N, Angeloudis K, Guppy FM, Singleton P, Miller M, Pigozzi F, Pitsiladis YP. Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic. Sports Med Open. 2021 Mar 15;7(1):19. doi: 10.1186/s40798-021-00309-7. PMID: 33721127; PMCID: PMC7957452.
Copy Download .nbib Format: NLM
Hypovolemic shock induced by a large chest wall hematoma caused by a single rib fracture in an elderly patient.

Trauma case reports

Miyamoto K, Suzuki K, Nakamura M, Yamaga H, Ohno T, Sasaki J, Dohi K, Hayashi M.
PMID: 33816742
Trauma Case Rep. 2021 Mar 17;32:100459. doi: 10.1016/j.tcr.2021.100459. eCollection 2021 Apr.

Displaced rib fractures can injure intercostal vessels leading to chest wall hematomas. As the bleeding occurs within the vessel, compression of the vessel wall helps in preventing further bleeding. Therefore, chest wall hematomas rarely result in shock. A thin...

Cite
Miyamoto K, Suzuki K, Nakamura M, et al. Hypovolemic shock induced by a large chest wall hematoma caused by a single rib fracture in an elderly patient. Trauma Case Rep. 2021;32:100459doi: 10.1016/j.tcr.2021.100459.
Miyamoto, K., Suzuki, K., Nakamura, M., Yamaga, H., Ohno, T., Sasaki, J., Dohi, K., & Hayashi, M. (2021). Hypovolemic shock induced by a large chest wall hematoma caused by a single rib fracture in an elderly patient. Trauma case reports, 32100459. https://doi.org/10.1016/j.tcr.2021.100459
Miyamoto, Kazuyuki, et al. "Hypovolemic shock induced by a large chest wall hematoma caused by a single rib fracture in an elderly patient." Trauma case reports vol. 32 (2021): 100459. doi: https://doi.org/10.1016/j.tcr.2021.100459
Miyamoto K, Suzuki K, Nakamura M, Yamaga H, Ohno T, Sasaki J, Dohi K, Hayashi M. Hypovolemic shock induced by a large chest wall hematoma caused by a single rib fracture in an elderly patient. Trauma Case Rep. 2021 Mar 17;32:100459. doi: 10.1016/j.tcr.2021.100459. eCollection 2021 Apr. PMID: 33816742; PMCID: PMC8010857.
Copy Download .nbib Format: NLM
Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.

JAMA network open

Cohn I, Manshaei R, Liston E, Okello JBA, Khan R, Curtis MR, Krupski AJ, Jobling RK, Kalbfleisch K, Paton TA, Reuter MS, Hayeems RZ, Verstegen RHJ, Goldman A, Kim RH, Ito S.
PMID: 34037732
JAMA Netw Open. 2021 May 03;4(5):e2110446. doi: 10.1001/jamanetworkopen.2021.10446.

IMPORTANCE: Pharmacogenomic (PGx) testing provides preemptive pharmacotherapeutic guidance regarding the lack of therapeutic benefit or adverse drug reactions of PGx targeted drugs. Pharmacogenomic information is of particular value among children with complex medical conditions who receive multiple medications and...

Cite
Cohn I, Manshaei R, Liston E, et al. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA Netw Open. 2021;4(5):e2110446doi: 10.1001/jamanetworkopen.2021.10446.
Cohn, I., Manshaei, R., Liston, E., Okello, J. B. A., Khan, R., Curtis, M. R., Krupski, A. J., Jobling, R. K., Kalbfleisch, K., Paton, T. A., Reuter, M. S., Hayeems, R. Z., Verstegen, R. H. J., Goldman, A., Kim, R. H., & Ito, S. (2021). Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA network open, 4(5), e2110446. https://doi.org/10.1001/jamanetworkopen.2021.10446
Cohn, Iris, et al. "Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting." JAMA network open vol. 4,5 (2021): e2110446. doi: https://doi.org/10.1001/jamanetworkopen.2021.10446
Cohn I, Manshaei R, Liston E, Okello JBA, Khan R, Curtis MR, Krupski AJ, Jobling RK, Kalbfleisch K, Paton TA, Reuter MS, Hayeems RZ, Verstegen RHJ, Goldman A, Kim RH, Ito S. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA Netw Open. 2021 May 03;4(5):e2110446. doi: 10.1001/jamanetworkopen.2021.10446. PMID: 34037732; PMCID: PMC8155824.
Copy Download .nbib Format: NLM
Showing 745 to 756 of 756 entries